PSMD6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.400600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.328800E-01
Normal-vs-Stage2
6.139800E-01
Normal-vs-Stage3
6.355200E-01
Normal-vs-Stage4
8.915800E-01
Stage1-vs-Stage2
7.040600E-01
Stage1-vs-Stage3
9.953000E-01
Stage1-vs-Stage4
5.484200E-01
Stage2-vs-Stage3
7.495800E-01
Stage2-vs-Stage4
6.556200E-01
Stage3-vs-Stage4
6.424400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.872400E-01
Normal-vs-AfricanAmerican
5.063000E-01
Normal-vs-Asian
4.147200E-01
Caucasian-vs-AfricanAmerican
6.513000E-01
Caucasian-vs-Asian
2.129000E-01
AfricanAmerican-vs-Asian
7.249200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.406800E-01
Normal-vs-Female
7.796200E-01
Male-vs-Female
2.259400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.278970E-01
Normal-vs-Age(41-60Yrs)
7.950600E-01
Normal-vs-Age(61-80Yrs)
6.105600E-01
Normal-vs-Age(81-100Yrs)
4.330800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.367800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.519800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.801800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.259200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.429400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.200400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.546200E-01
Normal-vs-Daily Drinker
3.103000E-01
Normal-vs-Weekly Drinker
5.004600E-01
Normal-vs-Occasional Drinker
9.313800E-01
Normal-vs-Social Drinker
4.585400E-01
Non Drinker-vs-Daily Drinker
2.666600E-01
Non Drinker-vs-Weekly Drinker
5.715200E-01
Non Drinker-vs-Occasional Drinker
5.640200E-01
Non Drinker-vs-Social Drinker
6.533400E-01
Daily Drinker-vs-Weekly Drinker
7.355200E-01
Daily Drinker-vs-Occasional Drinker
1.656810E-01
Daily Drinker-vs-Social Drinker
5.803000E-01
Weekly Drinker-vs-Occasional Drinker
3.836200E-01
Weekly Drinker-vs-Social Drinker
8.856200E-01
Occasional Drinker-vs-Social Drinker
4.089600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.086000E-01
Normal-vs-Grade 2
8.967400E-01
Normal-vs-Grade 3
9.193800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.048400E-01
Grade 1-vs-Grade 3
6.383400E-01
Grade 1-vs-Grade 4
9.086000E-01
Grade 2-vs-Grade 3
6.983400E-01
Grade 2-vs-Grade 4
8.967400E-01
Grade 3-vs-Grade 4
9.193800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.480200E-01
Normal-vs-NonDiabetic
5.515600E-01
Diabetic-vs-NonDiabetic
7.309200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.289600E-01
Normal-vs-NoPancreatitis
5.963200E-01
Pancreatitis-vs-NoPancreatitis
2.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.723200E-01
Normal-vs-N1
6.693000E-01
N0-vs-N1
8.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.845200E-01
Normal-vs-TP53-NonMutant
7.715200E-01
TP53-Mutant-vs-TP53-NonMutant
1.477050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
